{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:19:33Z","timestamp":1761059973437},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,7,30]],"date-time":"2015-07-30T00:00:00Z","timestamp":1438214400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Orthop Surg Res"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s13018-015-0264-y","type":"journal-article","created":{"date-parts":[[2015,7,29]],"date-time":"2015-07-29T10:54:50Z","timestamp":1438167290000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Are biological agents toxic to human chondrocytes and osteocytes?"],"prefix":"10.1186","volume":"10","author":[{"given":"Mehmet","family":"Isyar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bulent","family":"Bilir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Selami","family":"Cakmak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duygu Yasar","family":"Sirin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aliye Yildirim","family":"Guzelant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahir","family":"Mahirogullari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,7,30]]},"reference":[{"key":"264_CR1","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/978-1-4939-0956-8_16","volume":"1175","author":"D Sen","year":"2014","unstructured":"Sen D, Paul JR, Ranganathan P. Pharmacogenetics in rheumatoid arthritis. Methods Mol Biol. 2014;1175:625\u201360.","journal-title":"Methods Mol Biol"},{"key":"264_CR2","doi-asserted-by":"crossref","first-page":"525","DOI":"10.2174\/138920101506140910150227","volume":"15","author":"Y Li","year":"2014","unstructured":"Li Y, Wang Y, Shi G. Progress of biological agents on psoriatic arthritis. Curr Pharm Biotechnol. 2014;15:525\u201334.","journal-title":"Curr Pharm Biotechnol"},{"issue":"14","key":"264_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta15140","volume":"15","author":"K Malottki","year":"2011","unstructured":"Malottki K, Barton P, Tsourapas A, Uthman AO, Liu Z, Routh K, et al. Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a tumour necrosis factor inhibitor: a systematic review and economic evaluation. Health Technol Assess. 2011;15(14):1\u2013278.","journal-title":"Health Technol Assess"},{"issue":"1","key":"264_CR4","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s10067-013-2392-2","volume":"33","author":"N Takahashi","year":"2014","unstructured":"Takahashi N, Kojima T, Kaneko A, Kida D, Hirano Y, Fujibayashi T, et al. Clinical efficacy of abatacept compared to adalimumab and tocilizumab in rheumatoid arthritis patients with high disease activity. Clin Rheumatol. 2014;33(1):39\u201347.","journal-title":"Clin Rheumatol"},{"issue":"4","key":"264_CR5","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00281-006-0013-8","volume":"27","author":"P Hasler","year":"2006","unstructured":"Hasler P. Biological therapies directed against cells in autoimmune disease. Springer Semin Immunopathol. 2006;27(4):443\u201356.","journal-title":"Springer Semin Immunopathol"},{"issue":"3","key":"264_CR6","first-page":"204","volume":"71","author":"JU Scher","year":"2013","unstructured":"Scher JU. Monotherapy in rheumatoid arthritis. Bull Hosp Jt Dis (2013). 2013;71(3):204\u20137.","journal-title":"Bull Hosp Jt Dis (2013)"},{"issue":"6","key":"264_CR7","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.3899\/jrheum.090074","volume":"36","author":"M Mertens","year":"2009","unstructured":"Mertens M, Singh JA. Anakinra for rheumatoid arthritis: a systematic review. J Rheumatol. 2009;36(6):1118\u201325.","journal-title":"J Rheumatol"},{"key":"264_CR8","first-page":"623","volume":"40","author":"R Movva","year":"2013","unstructured":"Movva R, Brown SB, Morris DL, Figueredo VM. Anakinra for myocarditis in juvenile idiopathic arthritis. Tex Heart Inst J. 2013;40:623\u20135.","journal-title":"Tex Heart Inst J"},{"key":"264_CR9","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1136\/annrheumdis-2013-204417","volume":"73","author":"S Das","year":"2014","unstructured":"Das S, Vital EM, Horton S, Bryer D, El-Sherbiny Y, Rawstron AC, et al. Abatacept or tocilizumab after rituximab in rheumatoid arthritis? An exploratory study suggests non-response to rituximab is associated with persistently high IL-6 and better clinical response to IL-6 blocking therapy. Ann Rheum Dis. 2014;73:909\u201312.","journal-title":"Ann Rheum Dis"},{"key":"264_CR10","first-page":"2398","volume":"33","author":"G Gartlehner","year":"2006","unstructured":"Gartlehner G, Hansen RA, Jonas BL, Thieda P, Lohr KN. The comparative efficacy and safety of biologics for the treatment of rheumatoid arthritis: a systematic review and metaanalysis. J Rheumatol. 2006;33:2398\u2013408.","journal-title":"J Rheumatol"},{"key":"264_CR11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1136\/bjophthalmol-2014-305302","volume":"98","author":"D Malik","year":"2014","unstructured":"Malik D, Tarek M, Caceres del Carpio J, Ramirez C, Boyer D, Kenney MC, et al. Safety profiles of anti-VEGF drugs: bevacizumab ranibizumab aflibercept and ziv-aflibercept on human retinal pigment epithelium cells in culture. Br J Ophthalmol. 2014;98:11\u20136.","journal-title":"Br J Ophthalmol"},{"key":"264_CR12","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1136\/ard.16.4.494","volume":"16","author":"JH Kellgren","year":"1957","unstructured":"Kellgren JH, Lawrence JS. Radiological assessment of osteo-arthritis. Ann Rheum Dis. 1957;16:494\u2013502.","journal-title":"Ann Rheum Dis"},{"key":"264_CR13","doi-asserted-by":"crossref","first-page":"18","DOI":"10.5336\/medsci.2011-27807","volume":"33","author":"I Yilmaz","year":"2013","unstructured":"Yilmaz I, Gokay NS, Gokce A, Tonbul M, Gokce C. A novel designed chitosan based hydrogel which is capable of consecutively controlled release of TGF-beta 1 and BMP-7. Turkiye Klinikleri Journal of Medical Sciences. 2013;33:18\u201332.","journal-title":"Turkiye Klinikleri Journal of Medical Sciences"},{"key":"264_CR14","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3944\/AOTT.2014.2635","volume":"48","author":"A Gokce","year":"2014","unstructured":"Gokce A, Yilmaz I, Gokay NS, Can L, Gokce C. Does insulin transferrin and selenous acid preparation effect chondrocyte proliferation? Acta Orthop Traumatol Turc. 2014;48:313\u20139.","journal-title":"Acta Orthop Traumatol Turc"},{"key":"264_CR15","first-page":"7","volume":"6","author":"I Yilmaz","year":"2013","unstructured":"Yilmaz I, Gokay NS, Gokce A. In-vitro differentiation: from a primary cell to the osteoblast. Turkiye Klinikleri J Orthop & Traumatol-Special Topics. 2013;6:7\u201315.","journal-title":"Turkiye Klinikleri J Orthop & Traumatol-Special Topics"},{"key":"264_CR16","doi-asserted-by":"crossref","first-page":"065004","DOI":"10.1088\/1748-6041\/9\/6\/065004","volume":"9","author":"L Zheng","year":"2014","unstructured":"Zheng L, Jiang X, Chen X, Fan H, Zhang X. Evaluation of novel in situ synthesized nano-hydroxyapatite\/collagen\/alginate hydrogels for osteochondral tissue engineering. Biomed Mater. 2014;9:065004.","journal-title":"Biomed Mater"},{"key":"264_CR17","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1177\/153537020122600603","volume":"226","author":"JJ Minguell","year":"2001","unstructured":"Minguell JJ, Erices A, Conget P. Mesenchymal stem cells. Exp Biol Med (Maywood). 2001;226:507\u201320.","journal-title":"Exp Biol Med (Maywood)"},{"issue":"37","key":"264_CR18","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1365-2710.2011.01292.x","volume":"2012","author":"M Gallego-Galisteo","year":"2012","unstructured":"Gallego-Galisteo M, Villa-Rubio A, Alegre-del Rey E, M\u00e1rquez-Fern\u00e1ndez E, Ramos-B\u00e1ez JJ. Indirect comparison of biological treatments in refractory rheumatoid arthritis. J Clin Pharm Ther. 2012;2012(37):301\u20137.","journal-title":"J Clin Pharm Ther"},{"key":"264_CR19","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3944\/AOTT.2012.2606","volume":"46","author":"T Beyzadeoglu","year":"2012","unstructured":"Beyzadeoglu T, Torun KG, Ekinci ID, Bekler H, Yilmaz C. Cytotoxicity of local anesthetics to rats\u2019 articular cartilage: an experimental study. Acta Orthop Traumatol Turc. 2012;46:201\u20137.","journal-title":"Acta Orthop Traumatol Turc"},{"key":"264_CR20","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1007\/s00264-014-2445-4","volume":"38","author":"A Marmotti","year":"2014","unstructured":"Marmotti A, de Girolamo L, Bonasia DE, Bruzzone M, Mattia S, Rossi R, et al. Bone marrow derived stem cells in joint and bone diseases: a concise review. Int Orthop. 2014;38:1787\u2013801.","journal-title":"Int Orthop"},{"key":"264_CR21","doi-asserted-by":"crossref","first-page":"406","DOI":"10.2174\/1874325001206010406","volume":"6","author":"A Gokce","year":"2012","unstructured":"Gokce A, Yilmaz I, Bircan R, Tonbul M, Gokay NS, Gokce C. Synergistic effect of TGF-\u03b21 and BMP-7 on chondrogenesis and extracellular matrix synthesis: an in vitro study. Open Orthop J. 2012;6:406\u201313.","journal-title":"Open Orthop J"},{"key":"264_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1517\/17425255.2014.970165","volume":"10","author":"G Murdaca","year":"2014","unstructured":"Murdaca G, Span\u00f2 F, Contatore M, Guastalla A, Magnani O, Puppo F. Pharmacogenetics of etanercept: role of TNF-\u03b1 gene polymorphisms in improving its efficacy. Expert Opin Drug Metab Toxicol. 2014;10:1\u20138.","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"264_CR23","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1002\/jor.21091","volume":"8","author":"W Goodwin","year":"2010","unstructured":"Goodwin W, McCabe D, Sauter E, Reese E, Walter M, Buckwalter JA, et al. Rotenone prevents impact-induced chondrocyte death. J Orthop Res. 2010;8:1057\u201363.","journal-title":"J Orthop Res"},{"key":"264_CR24","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1093\/rheumatology\/ket355","volume":"53","author":"LK Stamp","year":"2014","unstructured":"Stamp LK, Barclay M. Therapeutic drug monitoring in rheumatic diseases: utile or futile? Rheumatology (Oxford). 2014;53:988\u201397.","journal-title":"Rheumatology (Oxford)"},{"key":"264_CR25","doi-asserted-by":"crossref","first-page":"7914","DOI":"10.3748\/wjg.v20.i24.7914","volume":"28","author":"A Elsner","year":"2014","unstructured":"Elsner A, Lange F, Fitzner B, Heuschkel M, Krause BJ, Jaster R. Distinct antifibrogenic effects of erlotinib sunitinib and sorafenib on rat pancreatic stellate cells. World J Gastroenterol. 2014;28:7914\u201325.","journal-title":"World J Gastroenterol"},{"key":"264_CR26","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1177\/0363546509359680","volume":"38","author":"JL Dragoo","year":"2010","unstructured":"Dragoo JL, Korotkova T, Kim HJ, Jagadish A. Chondrotoxicity of low pH epinephrine and preservatives found in local anesthetics containing epinephrine. Am J Sports Med. 2010;38:1154\u20139.","journal-title":"Am J Sports Med"},{"key":"264_CR27","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.arthro.2008.12.003","volume":"25","author":"A Anz","year":"2009","unstructured":"Anz A, Smith MJ, Stoker A, Linville C, Markway H, Branson K, et al. The effect of bupivacaine and morphine in a coculture model of diarthrodial joints. Arthroscopy. 2009;25:225\u201331.","journal-title":"Arthroscopy"},{"key":"264_CR28","first-page":"404","volume":"11","author":"J Hao","year":"2009","unstructured":"Hao J, Varshney RR, Wang DA. Engineering osteogenesis and chondrogenesis with gene-enhanced therapeutic cells. Curr Opin Mol Ther. 2009;11:404\u201310.","journal-title":"Curr Opin Mol Ther"},{"key":"264_CR29","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1007\/s11999-011-1834-x","volume":"469","author":"HM Syed","year":"2011","unstructured":"Syed HM, Green L, Bianski B. Bupivacaine and triamcinolone may be toxic to human chondrocytes: a pilot study. Clin Orthop Relat Res. 2011;469:2941\u20137.","journal-title":"Clin Orthop Relat Res"},{"key":"264_CR30","first-page":"20","volume-title":"Basic and clinical pharmacology","author":"NHG Holford","year":"2015","unstructured":"Holford NHG. Drug receptors and pharmacodynamics. In: Katzung B, Trevor A, editors. Basic and clinical pharmacology. California: McGrraw-Hill Companies Inc., Lange Medical Publications; 2015. p. 20\u201341."},{"key":"264_CR31","first-page":"56","volume-title":"Basic and clinical pharmacology","author":"MA Correia","year":"2015","unstructured":"Correia MA. Drug biotransformation. In: Katzung B, Trevor A, editors. Basic and clinical pharmacology. California: McGrraw-Hill Companies Inc., Lange Medical Publications; 2015. p. 56\u201374."},{"key":"264_CR32","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1002\/art.23447","volume":"58","author":"H Mitoma","year":"2008","unstructured":"Mitoma H, Horiuchi T, Tsukamoto H, Tamimoto Y, Kimoto Y, Uchino A, et al. Mechanisms for cytotoxic effects of anti-tumor necrosis factor agents on transmembrane tumor necrosis factor alpha-expressing cells: comparison among infliximab, etanercept, and adalimumab. Arthritis Rheum. 2008;58:1248\u201357.","journal-title":"Arthritis Rheum"},{"key":"264_CR33","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1365-2036.2005.02309.x","volume":"21","author":"C Shen","year":"2005","unstructured":"Shen C, Assche GV, Colpaert S, Maerten P, Geboes K, Rutgeers P, et al. Adalimumab induces apoptosis of human monocytes: a comparative study with infliximab and etanercept. Aliment Pharmacol Ther. 2005;21:251\u20138.","journal-title":"Aliment Pharmacol Ther"},{"key":"264_CR34","doi-asserted-by":"crossref","first-page":"6527","DOI":"10.4238\/2013.December.11.4","volume":"12","author":"Y Hu","year":"2003","unstructured":"Hu Y, Tang XX, He HY. Gene expression during induced differentiation of sheep bone marrow mesenchymal stem cells into osteoblasts. Genet Mol Res. 2003;12:6527\u201334.","journal-title":"Genet Mol Res"}],"container-title":["Journal of Orthopaedic Surgery and Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-015-0264-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13018-015-0264-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-015-0264-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,6]],"date-time":"2020-09-06T16:27:14Z","timestamp":1599409634000},"score":1,"resource":{"primary":{"URL":"http:\/\/josr-online.biomedcentral.com\/articles\/10.1186\/s13018-015-0264-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,30]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["264"],"URL":"https:\/\/doi.org\/10.1186\/s13018-015-0264-y","relation":{},"ISSN":["1749-799X"],"issn-type":[{"value":"1749-799X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,30]]},"article-number":"118"}}